Oral zinc therapy for zinc deficiency-related telogen effluvium.
Study Design
- 연구 유형
- Case Reports
- 표본 크기
- 5
- 중재
- Oral zinc therapy for zinc deficiency-related telogen effluvium. oral zinc administration as polaprezinc (Promac®)
- 대조군
- Placebo
- 효과 방향
- Positive
- 비뚤림 위험
- High
Abstract
Zinc is crucial for maintaining human body homeostasis and is one of the major components of hormones, signal molecules, and enzymes. Zinc deficiency is caused by insufficient uptake of zinc from food, or caused by malabsorption syndromes, increased gastrointestinal and urinary losses, and administration of various medications. In order to test whether oral zinc administration can successfully improve zinc deficiency-related alopecia, we treated five patients with zinc deficiency-related telogen effluvium with oral zinc administration in the form of polaprezinc (Promac®). In all patients, hair loss was cured or improved. The administration of zinc for zinc deficiency-related alopecia may recover appropriate activities of metalloenzymes, hedgehog signaling, and immunomodulation, all of which are required for normal control of hair growth cycle.
Used In Evidence Reviews
Similar Papers
Nature · 2010
Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.
Journal of the American Academy of Dermatology · 2006
The diagnosis and treatment of iron deficiency and its potential relationship to hair loss.
Clinical and experimental dermatology · 1989
Juvenile versus maturity-onset alopecia areata--a comparative retrospective clinical study.
American journal of clinical dermatology · 2005
Dermatologic signs in patients with eating disorders.
Archives of biochemistry and biophysics · 2016
Zinc and skin biology.
Annals of dermatology · 2013